Loading
Medical oncologist who co-chairs the breast disease group at The Christie, the Manchester cancer centre that is a site of the PHOENIX, PARTNER and ASCENT-05 trials for triple-negative disease.
Anne Armstrong is a consultant in medical oncology and honorary senior lecturer at The Christie NHS Foundation Trust in Manchester, where her consultant page lists breast cancer as her specialty and names her co-chair of the trust's Breast Disease Group. The Christie's breast clinical oncology team provides radiotherapy, systemic anti-cancer treatment and specialised surgery for the region, and the trust is a UK site of the PHOENIX window-of-opportunity trial in residual triple-negative disease, of PARTNER and of ASCENT-05. Her name appears as investigator on The Christie's news pages about breast trials.
Shares Breast cancer (all types), Triple-negative breast cancer (TNBC) and the tags breast, uk.
Shares Breast cancer (all types), Triple-negative breast cancer (TNBC) and the tags breast, uk.
Shares Triple-negative breast cancer (TNBC) and the tags breast, uk.
Shares Triple-negative breast cancer (TNBC) and the tags breast, uk.
Shares Triple-negative breast cancer (TNBC) and the tags breast, uk.
Shares Breast cancer (all types), Triple-negative breast cancer (TNBC) and the tag breast.
Shares Breast cancer (all types), Triple-negative breast cancer (TNBC) and the tag breast.
Shares Breast cancer (all types), Triple-negative breast cancer (TNBC) and the tag breast.